Model
Edge
Cidara Therapeutics Inc.
CDTX
Filing type
10-Q
Filing date
Aug 6, 2025
Updated
Aug 7, 2025 ยท 2:15 PM
Copy reference
Filing
10-Q
Q2
Exhibits
EX-31.1
CERTIFICATION OF CEO PURSUANT TO SECURITIES EXCHANGE ACT OF 1934
EX-31.2
CERTIFICATION OF CFO PURSUANT TO SECURITIES EXCHANGE ACT OF 1934
EX-32.1
CERTIFICATION OF CEO PURSUANT TO SARBANES-OXLEY ACT OF 2002
EX-32.2
CERTIFICATION OF CFO PURSUANT TO SARBANES-OXLEY ACT OF 2002